Closed Loop Medicine

#Cardiovascular disease #Closed Loop Medicine #GLP-1 #US patent

Closed Loop Medicine secures US patents for GLP-1 therapies

Closed Loop Medicine has been granted US patents covering advancements in GLP-1 therapies for obesity and diabetes, and direct oral anticoagulants (DOACs) for cardiovascular health.  The company currently holds over 65 filings across 16 patent families.   In the rapidly-established GLP-1 market, the company’s IP covers… Read More

#Business & Investment #News

#Business #Closed Loop Medicine #NVIDIA #Start-ups

Closed Loop Medicine joins NVIDIA Inception programme

Closed Loop Medicine has joined the NVIDIA Inception accelerator programme, designed to nurture start-ups and early-stage companies revolutionising industries with technological advancements. The programme supports all stages of a start-up’s life cycle, providing access to the latest tools, expertise, and a network of venture capitalist investors,… Read More

#Business & Investment #News #Start-up Zone